Entrez Id: |
100124696 |
Gene Symbol: |
TEC |
TEC
|
|
transient erythroblastopenia of childhood
|
|
40
|
0.659 |
0.577 |
|
0.010 |
None
|
1.000 |
1
|
0
|
1999 |
1999 |
Entrez Id: |
100132417 |
Gene Symbol: |
FCGR1CP |
FCGR1CP
|
|
Fc fragment of IgG receptor Ic, pseudogene
|
|
17
|
0.769 |
0.462 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2017 |
2017 |
KLRC4-KLRK1
|
P26718
|
KLRC4-KLRK1 readthrough
|
|
246
|
0.469 |
0.769 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2015 |
2015 |
Entrez Id: |
107075310 |
Gene Symbol: |
MTCO2P12 |
MTCO2P12
|
|
MT-CO2 pseudogene 12
|
|
703
|
0.368 |
0.962 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2006 |
2006 |
Entrez Id: |
10934 |
Gene Symbol: |
MORF4 |
MORF4
|
|
mortality factor 4 (pseudogene)
|
|
25
|
0.705 |
0.423 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2020 |
2020 |
Entrez Id: |
110006328 |
Gene Symbol: |
ERVK-32 |
ERVK-32
|
|
endogenous retrovirus group K member 32, envelope
|
|
158
|
0.522 |
0.692 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2003 |
2003 |
Entrez Id: |
115482696 |
Gene Symbol: |
H3P23 |
H3P23
|
|
H3 histone pseudogene 23
|
|
310
|
0.443 |
0.769 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2005 |
2005 |
Entrez Id: |
1483 |
Gene Symbol: |
CTAA1 |
CTAA1
|
|
cataract, anterior polar 1
|
|
106
|
0.568 |
0.731 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2018 |
2018 |
Entrez Id: |
29128 |
Gene Symbol: |
UHRF1 |
UHRF1
|
Q96T88
|
ubiquitin like with PHD and ring finger domains 1
|
|
125
|
0.540 |
0.692 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
HLA-DRB3
|
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
85
|
0.570 |
0.885 |
|
0.010 |
None
|
1.000 |
1
|
0
|
1999 |
1999 |
Entrez Id: |
3440 |
Gene Symbol: |
IFNA2 |
IFNA2
|
P01563
|
interferon alpha 2
|
|
355
|
0.442 |
0.885 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2014 |
2014 |
Entrez Id: |
400500 |
Gene Symbol: |
BCAR4 |
BCAR4
|
|
breast cancer anti-estrogen resistance 4
|
|
40
|
0.653 |
0.346 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2010 |
2010 |
Entrez Id: |
406910 |
Gene Symbol: |
MIR125A |
MIR125A
|
|
microRNA 125a
|
|
225
|
0.480 |
0.769 |
|
0.010 |
None
|
< 0.001 |
1
|
0
|
2016 |
2016 |
Entrez Id: |
406949 |
Gene Symbol: |
MIR15B |
MIR15B
|
|
microRNA 15b
|
|
134
|
0.532 |
0.769 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2015 |
2015 |
Entrez Id: |
406980 |
Gene Symbol: |
MIR19B1 |
MIR19B1
|
|
microRNA 19b-1
|
|
144
|
0.529 |
0.769 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2015 |
2015 |
Entrez Id: |
407004 |
Gene Symbol: |
MIR22 |
MIR22
|
|
microRNA 22
|
|
195
|
0.496 |
0.808 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2010 |
2010 |
Entrez Id: |
407018 |
Gene Symbol: |
MIR27A |
MIR27A
|
|
microRNA 27a
|
|
248
|
0.466 |
0.846 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2015 |
2015 |
Entrez Id: |
407021 |
Gene Symbol: |
MIR29A |
MIR29A
|
|
microRNA 29a
|
|
278
|
0.459 |
0.808 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2017 |
2017 |
Entrez Id: |
4513 |
Gene Symbol: |
COX2 |
COX2
|
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
875
|
0.352 |
0.962 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2006 |
2006 |
Entrez Id: |
64006 |
Gene Symbol: |
ERVK-6 |
ERVK-6
|
|
endogenous retrovirus group K member 6, envelope
|
|
162
|
0.521 |
0.808 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2003 |
2003 |
Entrez Id: |
7063 |
Gene Symbol: |
THM |
THM
|
|
thymoma
|
|
30
|
0.686 |
0.500 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
780897 |
Gene Symbol: |
HPP1 |
HPP1
|
|
hyperpigmentation, progressive, 1
|
|
35
|
0.686 |
0.346 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2009 |
2009 |
Entrez Id: |
7864 |
Gene Symbol: |
SCLC1 |
SCLC1
|
|
small cell cancer of the lung
|
|
73
|
0.612 |
0.577 |
|
0.010 |
None
|
1.000 |
1
|
0
|
2019 |
2019 |
Entrez Id: |
8205 |
Gene Symbol: |
TAM |
TAM
|
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
141
|
0.528 |
0.731 |
|
0.010 |
None
|
1.000 |
1
|
0
|
1998 |
1998 |
Entrez Id: |
7273 |
Gene Symbol: |
TTN |
TTN
|
Q8WZ42
|
titin
|
Kinase
|
366
|
0.470 |
0.885 |
2.6E-96 |
0.050 |
None
|
1.000 |
5
|
0
|
1993 |
2018 |